Nancy Reau, DDW 2021: Hepatic Manifestations of COVID-19

It was a pleasure to speak with Prof. Nancy Reau (Rush Medical College, Chicago, IL, USA) about the hepatic manifestations of COVID-19 infection.

Her presentation entitled ‘HEPATIC MANIFESTATIONS OF COVID-19: IS THERE CAUSE FOR CONCERN?’ was given at DDW, 21-23 May 2021 May 2021.

Questions

1. Could you give us a brief overview of the spectrum of hepatic manifestations of COVID-19? (0:10)
2. Which patients are most likely to have elevated ALT/AST elevation and bilirubin and how long do these elevated levels typically persist? (1:37)
3. What are the consequences of these elevations in terms of liver injury and COVID mortality? (2:38)
4. What have we learned about progressive cholangiopathy in COVID-19 patients? (3:20)

Disclosures: Prof. Nancy Reau has nothing to disclose in relation to this video interview.

Support: Interview and filming supported by Touch Medical Media. Interview conducted by Gina Furnival.

Filmed in coverage of DDW 2021.